# Adverse Event Report Form

## Study Information
- **Study Title**: ______________________________
- **Protocol Number**: ______________________________
- **Study Phase**: ☐ I  ☐ II  ☐ III  ☐ IV

## Subject Information
- **Subject ID**: ______________________________
- **Subject Initials**: ______________________________
- **Age**: ________ years  **Sex**: ☐ M  ☐ F
- **Randomization Date**: ______________________________

## Event Information
- **AE Number**: ________ (sequential for this subject)
- **Report Date**: ______________________________
- **Reporter**: ______________________________

### Event Description
**Verbatim Term** (patient's words): ______________________________

**Diagnosis/Medical Term** (MedDRA Preferred Term): ______________________________

**Body System**: ______________________________

**Detailed Description/Narrative**:
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________

### Onset and Duration
- **Onset Date**: ____/____/________ (DD/MMM/YYYY)
- **Onset Time**: ______:______ (if known)
- **End Date**: ____/____/________ or ☐ Ongoing
- **End Time**: ______:______ (if known)
- **Duration**: ________ days/hours

### Event Classification

**Intensity/Severity (CTCAE v5.0)**:
- ☐ Grade 1 (Mild) - Minimal symptoms, intervention not indicated
- ☐ Grade 2 (Moderate) - Minimal intervention indicated, limiting instrumental ADL
- ☐ Grade 3 (Severe) - Medically significant, hospitalization indicated, limiting self-care ADL
- ☐ Grade 4 (Life-threatening) - Urgent intervention indicated
- ☐ Grade 5 (Death) - Death related to AE

**Justification for Severity Grade**:
________________________________________________________________________

**Seriousness**:
- ☐ NOT Serious
- ☐ SERIOUS - Check all criteria met:
  - ☐ Death
  - ☐ Life-threatening (immediate risk of death)
  - ☐ Hospitalization (initial or prolonged)
  - ☐ Persistent or significant disability/incapacity
  - ☐ Congenital anomaly/birth defect
  - ☐ Important medical event (specify): ______________________________

**Expectedness**:
- ☐ Expected (listed in current IB/label)
- ☐ Unexpected (not in IB or greater severity/specificity)

### Causality Assessment

**Relationship to Study Drug**:
- ☐ Unrelated - Clearly due to other cause
- ☐ Unlikely - Doubtful relationship
- ☐ Possible - Could be related
- ☐ Probable - Likely related
- ☐ Definite - Certainly related

**Rationale for Causality Assessment**:
________________________________________________________________________
________________________________________________________________________

**Relationship to Study Procedures**:
- ☐ Unrelated  ☐ Unlikely  ☐ Possible  ☐ Probable  ☐ Definite

### Temporal Relationship
- **Study Day of Onset**: Day ________ (Day 1 = first dose)
- **Last Dose Before Event**: ____/____/________
- **Time from Last Dose to Event**: ________ hours/days

### Alternative Causes Considered
- ☐ Underlying disease progression
- ☐ Concomitant medication (specify): ______________________________
- ☐ Pre-existing condition (specify): ______________________________
- ☐ Other (specify): ______________________________

### Dechallenge
- **Was study drug stopped or reduced?**: ☐ Yes  ☐ No  ☐ N/A
- **Did event improve after stopping/reducing?**: ☐ Yes  ☐ No  ☐ N/A  ☐ Ongoing
- **Time to improvement**: ________ hours/days

### Rechallenge
- **Was study drug restarted?**: ☐ Yes  ☐ No  ☐ N/A
- **Did event recur?**: ☐ Yes  ☐ No  ☐ N/A

## Action Taken

**Action Taken with Study Drug**:
- ☐ None - Dose continued unchanged
- ☐ Dose reduced (new dose: ________)
- ☐ Drug temporarily interrupted (dates: ____/____/________ to ____/____/________)
- ☐ Drug permanently discontinued (date: ____/____/________)

**Treatment for Adverse Event**:
- ☐ None
- ☐ Non-drug therapy (specify): ______________________________
- ☐ Medication given:
  - Drug name: ______________________________
  - Dose/frequency: ______________________________
  - Start date: ____/____/________
  - Stop date: ____/____/________ or ☐ Continuing

**Other Interventions**:
- ☐ Hospitalization (dates: ____/____/________ to ____/____/________)
- ☐ Emergency room visit
- ☐ Procedure performed (specify): ______________________________
- ☐ Other (specify): ______________________________

## Outcome

**Event Outcome**:
- ☐ Recovered/Resolved (date: ____/____/________)
- ☐ Recovering/Resolving
- ☐ Not recovered/Not resolved
- ☐ Recovered with sequelae (describe): ______________________________
- ☐ Fatal (date of death: ____/____/________)
- ☐ Unknown

**If Fatal**:
- **Cause of Death (primary)**: ______________________________
- **Contributing Causes**: ______________________________
- **Was event the primary cause of death?**: ☐ Yes  ☐ No
- **Autopsy performed?**: ☐ Yes  ☐ No
- **Autopsy results available?**: ☐ Yes ☐ No ☐ Pending

## Relevant Laboratory Data

| Test | Date | Value | Units | Normal Range | CTCAE Grade |
|------|------|-------|-------|--------------|-------------|
|      |      |       |       |              |             |
|      |      |       |       |              |             |

## Follow-Up

**Follow-up Needed**: ☐ Yes  ☐ No

**If Yes, specify**:
________________________________________________________________________

**Next Scheduled Follow-up Date**: ____/____/________

## Regulatory Reporting

**Sponsor Notified**:
- Date: ____/____/________ Time: ______:______
- Method: ☐ Phone  ☐ Email  ☐ Fax  ☐ EDC
- Person notified: ______________________________

**IRB Notified** (if required):
- Date: ____/____/________
- Method: ☐ Phone  ☐ Written report

**FDA Notified** (IND Safety Report, if applicable):
- ☐ 7-day report (fatal/life-threatening)
- ☐ 15-day report (other serious unexpected)
- ☐ Not required
- Report Date: ____/____/________

## Investigator Assessment

I have reviewed this adverse event report and confirm the information is accurate and complete.

**Investigator Name (print)**: ______________________________

**Signature**: _________________________ **Date**: ____/____/________

---

**Form Version**: 1.0
**Form Date**: [Date]
